Agfa HealthCare Enterprise Imaging XERO Viewer — FDA record Z-1004-2023

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 5, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Agfa HealthCare Enterprise Imaging XERO Viewer
Reason
There is a software defect that can cause issues with images.
Classification
Class II
Recalling firm
Agfa Healthcare NV
Quantity
110 units
Agency-reported status
Ongoing
Source record identifier
Z-1004-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityAffected software versions include: XERO Viewer 8.1.4.100 or higher XERO Viewer 8.2.0.000 or higher XERO Viewer 8.2.1.000 or higher UDI/DI: 05400874000710

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Distribution throughout US OUS distribution to Australia, Belgium, Brazil, Canada, Chile, Cyprus, France, Iceland, Ireland, Italy, Kenya, Luxembourg, Netherlands, Romania, Saudi Arabia, Spain, Sweden, United Kingdom, South Africa

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Report date
Feb 1, 2023
Recall initiation date
Dec 5, 2022
Center classification date
Jan 20, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records